2021 Pediatric Grand Rounds | Application of Neuropsychology to Pediatric Oncology
Cancer continues to be life-threatening, which, for patients with poor outcomes, novel therapies are being offered, and for patients who have better outcomes, long-term side effects of toxic therapies are meaningful side effects of cancer therapy. For novel therapies, including immune checkpoint inhibitors and brain tumor CAR T-cell therapy, characterization of acute neurocognitive outcomes has clinical significance. For therapies that have been utilized for decades, long-term outcomes from these therapies are worth characterizing and integrating into clinical care. The purpose of this lecture is to update pediatric oncologists on the impact of cancer and its therapy on neurocognitive outcome among pediatric patients.
Target Audience
City of Hope Pediatric Hematology/Oncology Physicians, Advance Practice Practitioners, City of Hope staff and research teams.
Learning Objectives
- Identify short-term side effects of novel therapies and long-term side effects of standard therapies.
- Distinguish appropriate neurocognitive work-up and evaluation for pediatric oncology patients.
- Integrate strategies to mitigate neurocognitive toxicities in clinical care.
- Examine possible avenues to collaborate on future trials.
- Outline the various types of cultural diversities (gender, age, race, religion, culture, etc.) that relate to demographics, diagnosis and treatment.
Virtual Meeting- Zoom
Natalie C. Kelly, PhD, ABPP-CN Assistant Clinical Professor, Clinical Neuropsychologist; Director, Neuropsychology Clerkship; City of Hope
Dr. Kelly has indicated that she does not have anything to disclose.
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live webinar for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1 Credit™ 1.0
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
Available Credit
- 1.00 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this 2021 Pediatric Grand Rounds | Application of Neuropsychology to Pediatric Oncology for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 1.00 Attendance